Transcriptomics

Dataset Information

0

Major impact of sampling methodology on gene expression in estrogen receptor positive breast cancer


ABSTRACT: To investigate the impact of sampling methodology on gene expression data from primary estrogen receptor positive (ER+) breast cancer biopsies. Analysis of global gene-expression measured in core-cut biopsies at baseline and surgery from patients randomised to receive either 2-week’s presurgical aromatase inhibitor (AI, n=157) or no presurgical treatment (n=56) revealed genes most markedly altered in the AI group (e.g. FOS, DUSP1, RGS1, FOSB) were equally altered in the no-treatment group; some widely investigated genes that were apparently unaffected in the AI group (e.g. MYC) were counter-altered in the Control group masking actual AI-dependent changes. In the absence of a Control group these artefactual changes would likely lead to the most affected genes being the erroneous focus of research. The findings are likely relevant to all archival collections of ER+ breast cancer.

ORGANISM(S): Homo sapiens

PROVIDER: GSE105777 | GEO | 2018/10/22

REPOSITORIES: GEO

Similar Datasets

2020-02-24 | GSE126870 | GEO
2020-06-29 | GSE153470 | GEO
| phs000472 | dbGaP
2022-08-05 | GSE210399 | GEO
2018-05-11 | GSE114276 | GEO
2018-05-31 | GSE115099 | GEO
| EGAD00001002651 | EGA
| EGAS00001001940 | EGA
2010-10-23 | E-GEOD-24834 | biostudies-arrayexpress
2007-11-29 | E-GEOD-5666 | biostudies-arrayexpress